Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2001-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf8bf70beaa737024e575d702862010c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f058cd9da94db24e3298394667709c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa52964884d2141378f9cd0c92ea4f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e68419ea263b5c7716ce6b0e6b230694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481179613a8ce72ecb726bbbb371c2f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1835140b8139506d641c08f6348c1985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30d95b81667c16871fb3fe504438819 |
publicationDate |
2004-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-521183-A |
titleOfInvention |
Crystalline form of lopinavir |
abstract |
A crystalline hydrated form of lopinavir is disclosed. Such crystalline forms of lopinavir may have a peak in the solid state infrared spectrum at a position within the range 1652 - 1666 cm-1 and a peak in the solid state infrared spectrum at a position within the range 1606-1615 cm-1. |
priorityDate |
2000-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |